Mairs & Power Q1 2026 Update on UnitedHealth Group and Market Insights

Mairs & Power, an investment management firm, recently shared its Q1 2026 investor communication for the Mairs & Power Balanced Fund. In this period, the fund achieved a return of -1.77%, outperforming its composite benchmark index, which fell by -2.68%. Strategic stock selection and favorable positions in the Utilities and Industrials sectors were pivotal in mitigating market disruptions caused by geopolitical tensions in the Middle East and rising energy costs. These factors, coupled with inflationary pressures, led the Federal Reserve to take a cautious stance on interest rates. Despite uncertainties, the firm maintains a positive long-term outlook, citing robust corporate earnings and opportunities in Utilities, Industrials, and Health Care.

A standout in the investor letter was UnitedHealth Group Incorporated (NYSE:UNH), a significant health services provider offering insurance and healthcare delivery solutions. UnitedHealth Group reported a 3.30% return over the past month, with stock prices ranging from $234.60 to $404.15 over the past year. As of June 1, 2026, the stock closed at approximately $379.86, with a market capitalization of around $344.97 billion.

Addressing recent industry developments, Mairs & Power highlighted challenges faced by UnitedHealth Group due to the Center for Medicare & Medicaid Services' decision to implement a modest reimbursement increase for 2027, notably lower than the anticipated 5% for 2026. As a result, UnitedHealth Group foresees the need to cut benefits, potentially impacting volume and profitability. At the quarter's close, 130 hedge fund portfolios held positions in UnitedHealth Group, a drop from 145 in the previous quarter. Despite potential investment risks, Mairs & Power hinted that certain AI stocks could deliver higher returns in a shorter timeframe.